Advertisement

Topics

EHA19: ArQule reports positive Phase I data for ARQ 531 in haematological malignancies, shares rise https://firstwordpharma.com/node/1647573?tsid=28®ion_id=6 …

15:25 EDT 14 Jun 2019 | FirstWord Pharma

EHA19: ArQule reports positive Phase I data for ARQ 531 in haematological malignancies, shares rise https://firstwordpharma.com/node/1647573?tsid=28&region_id=6 …

Original Article: EHA19: ArQule reports positive Phase I data for ARQ 531 in haematological malignancies, shares rise https://firstwordpharma.com/node/1647573?tsid=28®ion_id=6 …

NEXT ARTICLE

More From BioPortfolio on "EHA19: ArQule reports positive Phase I data for ARQ 531 in haematological malignancies, shares rise https://firstwordpharma.com/node/1647573?tsid=28®ion_id=6 …"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...